Our medical expertise

Women’s Health

Genetic Conditions

Pediatric Health

Oncology

Haematology

Gastroenterology

Microbiome

Ultra-rare Diseases

Ultra-rare Diseases

Understanding the patient experience
is essential to know where to start

Our leadership team launched the first ultra-rare “blockbuster” in 2007. We’ve worked with the leader in making the ultra-rare disease space an innovative one. We’re beyond passionate because the deeper we go, the more we know that we are only at the tip of the iceberg. And ultra-rare diseases are often missed in the most fragile of patients. We work hand-in-hand with our clients, medical affairs, patient associations, and leverage our rich experience in order to bring real solutions to patients in need.

Gastroenterology

We understand that gut health is
essential to whole human health

5

million people worldwide have IBD

We’ve brought treatments to market in Crohn’s, UC, IBD and complementary treatments in the gut microbiome. We have worked with leading KOLs from around the world to build meaningful strategies to reduce the treatment burden and improve patients’ lives. We’ve built up large-scale strategies to educate HCPs and change protocols, and worked in parallel to empower patients to communicate with their HCPs, and find what they need to live better with their conditions.

GENETIC CONDITIONS

Evolving the NBS standard:
from Wilson & Jungner to a new algorithm

NBS

in Europe & the UK

Our medical team developed a custom newborn screening (NBS) algorithm. Hand-in-hand with a leading patient association and our client, our medical team designed an algorithm complementing the original criteria established by Wilson and Jungner. This new algorithm acts as a tool to aide governments and policy makers in determining which conditions could be screened. The hope is that this algorithm will help expand newborn screening programs across Europe, so that babies are tested, diagnosed and treated early for rare and severe genetic conditions.

Hematology

WHERE PASSION MEETS
EVIDENCE-BASED MEDICINE

Focused

on what those abnormalities mean

We’ve worked in cancers that are treacherous, mutating, and we know that we need to be as sharp and intentional in bringing treatment therapies to market to combat them. Our clients are leaders in complex cancers and we strive to build subject matter experts in our team. From tackling cancers such as CML, ALL, CML and NHL, to educating on radioligand therapies, we thrive in this space.

Microbiome

We speak genus and species and believe
that space is ripe with revolution

We’ve been lucky enough to be exposed to the human microbiome, including the gut, neurological and reproductive spaces. We’ve worked with leaders and researchers from the US and Europe to educate on the role of the microbiome, and how diseases can be managed and even reproductive challenges improved by creating symbiosis in the microbiome. We know our genus and our species and we believe that a revolution is just around the corner in the role of the microbiome and the potential origin of many conditions.

Oncology

The most complex cancers are the most
challenging – and intriguing

Because

the “Four Humors” theory remains relevant

We’ve worked in cancers that are treacherous, mutating, and we know that we need to be as sharp and intentional in bringing treatment therapies to market to combat them. Our clients are leaders in complex cancers and we strive to build subject matter experts in our team. From tackling cancers such as CML, ALL, CML and NHL, to educating on radioligand therapies, we thrive in this space.

Pediatric Health

Pediatric patients deserve precision;
there is NO margin fOR error

Children

face 6-9 illnesses per year

From launching the first vaccination against Rotavirus in Europe to commercializing novel treatment therapies in acute gastroentiritis, ultra-rare diseases and movement disorders, the pediatric space requires precision. We’ve worked to change protocols to improve earlier diagnosis. We’ve built taskforces including hospital staff, KOLs and researchers to change protocols - and ultimately, pediatric patient outcomes.

women’s health

Innovation is the path
forward.

17

YEARS EXPERIENCE

Our team has worked across the women’s health spectrum. We’ve launched the first HPV vaccination, we’ve worked with clients who wanted to improve contraception and invasive procedures. We’ve worked to prevent post-partum haemorrhage in underserved populations. We’ve worked late into the night to launch new therapies in metastatic breast cancer, and worked with a cutting edge diagnostics company to help women avoid chemotherapy. We’ve stood by a global leader in the cervical cancer, STI and cytology diagnostic space and continued to demonstrate that innovation is the path forward in Women’s Health.

How we can help you?